{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:47:17Z","timestamp":1789505237710,"version":"build-2803163510"},"reference-count":93,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Huntington's disease is a progressive neurodegenerative disorder for which therapies are woefully inadequate and do not prevent inevitable progression. Currently approved therapies are primarily aimed at treating chorea, but do not address the more clinically meaningful motor, behavioral, and cognitive features of the disease. However, there are a number of promising new therapies that are currently being studied in the laboratory, and in the clinic. This article will review the wide variety of therapies currently being tested, the advances in clinical trials and end points, and the many potentially relevant new targets. \u00a9 2018 International Parkinson and Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.27363","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T05:43:21Z","timestamp":1525758201000},"page":"1033-1041","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Huntington's disease: Current and future therapeutic prospects"],"prefix":"10.1002","volume":"33","author":[{"given":"Karl","family":"Kieburtz","sequence":"first","affiliation":[{"name":"University of Rochester, USA and Clintrex LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Reilmann","sequence":"additional","affiliation":[{"name":"George Huntington Institute, Munster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Warren","family":"Olanow","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine and Clintrex LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.1.1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004209"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003478"},{"issue":"12","key":"e_1_2_7_6_1","first-page":"2219","article-title":"A futility study of minocycline in Huntington's disease","volume":"25","author":"Huntington Study Group DOMINO Investigators","year":"2010","journal-title":"Mov Disord"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-011-9299-y"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.334"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamaneurol.382"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8655"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-017-0051-5"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12483"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3916"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16091037"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26330"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70262-5"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.11.025"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw238"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.3"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70233-2"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25362"},{"issue":"2","key":"e_1_2_7_23_1","first-page":"323","article-title":"Efficacy, safety, and tolerability of pridopidine in Huntington's disease (HD): results from the phase ii dose\u2010ranging study, Pride\u2010HD","volume":"32","author":"Reilmann R","year":"2017","journal-title":"Mov Disord"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep31652"},{"issue":"1","key":"e_1_2_7_25_1","first-page":"537","article-title":"Design of the LEGATO\u2010HD study: A multinational, randomized, double\u2010blind, placebo\u2010controlled, parallelgroup study to evaluate the efficacy and safety of laquinimod (0.5, 1.0 and 1.5 mg\/day) as treatment in patients with Huntington's disease","volume":"30","author":"Reilmann R","year":"2015","journal-title":"Mov Disord"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000367"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.01.002"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg046"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310226200"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1238-14.2015"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.146332"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.baga.2013.08.001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013417"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00018.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.t01-1-01868.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0202-143"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03357.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.04.001"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26101"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn273"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu010"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2559"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2558"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2624"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12512"},{"issue":"10","key":"e_1_2_7_46_1","doi-asserted-by":"crossref","first-page":"S47.004","DOI":"10.1212\/WNL.82.10_supplement.S47.004","article-title":"Safety and tolerability of selisistat for the treatment of Huntington's disease: results from a randomized, double\u2010blind, placebo\u2010controlled phase II trial","volume":"82","author":"Reilmann R","year":"2014","journal-title":"Neurology"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26174"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26026"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.25.13877"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24174"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1747"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61010-2"},{"key":"e_1_2_7_53_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-130057","article-title":"Antisense oligonucleotide\u2010mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease","volume":"2","author":"Stanek LM","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.05.009"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.7"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.17"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.219"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26020"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1206506109"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24436"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10720"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050202"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110204"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004743"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25175"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt192"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.24"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182020123"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70088-7"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26011"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21449"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.22055"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26174"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80743"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep12166"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70170-X"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00078"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70238-8"},{"key":"e_1_2_7_79_1","unstructured":"KilloranA BiglanK Julian\u2010BarosE YoritomotoN RossCA.Baseline characteristics of the PREQUEL cohort: an interventional trial in pre\u2010manifest Huntington's disease.2012:185."},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1302513"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45364"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23953"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26021"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1385\/MB:32:2:147"},{"key":"e_1_2_7_86_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington's disease","volume":"12","author":"Horsten S","year":"2003","journal-title":"Hum Mol Genet"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1148-12.2012"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-130050"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq063"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-130001"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2015.11.013"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2015.11.017"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26008"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25337"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.27363","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.27363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:01:20Z","timestamp":1760954480000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.27363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1002\/mds.27363"],"URL":"https:\/\/doi.org\/10.1002\/mds.27363","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733200457.793545975","asserted-by":"object"}]},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"2017-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}